Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00438386 · ClinicalTrials.gov registry record · Phase 4
Aripiprazole for the Treatment of Refractory Anxiety
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00438386: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT00438386 is a Phase 4 study that has completed, run by Massachusetts General Hospital. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00438386, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is to determine whether aripiprazole is effective in the treatment of refractory panic and generalized anxiety disorder.
Interventions
- DRUG Aripiprazole
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-04 |
| Est. Completion | 2007-06 |
| Phase | Phase 4 |
What the finished NCT00438386 record still lists
NCT00438386 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Aripiprazole is the first listed.
NCT00438386 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00438386 about?
NCT00438386 is a clinical study titled "Aripiprazole for the Treatment of Refractory Anxiety". The purpose of this study is to determine whether aripiprazole is effective in the treatment of refractory panic and generalized anxiety disorder.
What is the current status of trial NCT00438386?
This trial is currently completed. It is a Phase 4 study. The study started on 2005-04. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00438386?
The interventions under investigation include: Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT00438386?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia